Metabolic Syndrome for Cardiovascular Disease Morbidity and Mortality Among General Japanese People: A Mini Review

References

• Meigs JB. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol. 2000;152:908–911. doi:10.1093/aje/152.10.908
   PubMed Web of Science ®Google Scholar
• Haslam DW, James WP. Obesity. Lancet 2005; 366: 1197–1209. doi:10.1016/S0140-6736(05)67483-1
   PubMed Web of Science ®Google Scholar
• Müller MJ, Lagerpusch M, Enderle J, et al. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev. 2012;13:6–13. doi:10.1111/j.1467-789X.2012.01033.x
   PubMed Web of Science ®Google Scholar
• Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119:812–819. doi:10.1016/j.amjmed.2006.02.031
   PubMed Web of Science ®Google Scholar
• Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403–414. doi:10.1016/j.jacc.2006.09.032
   PubMed Web of Science ®Google Scholar
• Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113–1132. doi:10.1016/j.jacc.2010.05.034
   PubMed Web of Science ®Google Scholar
• Yoshiike N, Miyoshi M. Epidemiological aspects of overweight and obesity in Japan–international comparisons. Nihon Rinsho. 2013;71:207–216.
   PubMedGoogle Scholar
• Yang L, Colditz GA. Prevalence of overweight and obesity in the United States, 2007–2012. JAMA Intern Med. 2015;175:1412–1413. doi:10.1001/jamainternmed.2015.2405
   PubMed Web of Science ®Google Scholar
• Kivimäki M, Kuosma E, Ferrie JE, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health. 2017;2:e277—285. doi:10.1016/S2468-2667(17)30074-9
   PubMed Web of Science ®Google Scholar
• Ueshima H. Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb. 2007;14:278–286. doi:10.5551/jat.E529
   PubMed Web of Science ®Google Scholar
• Chen MS, John JM, Chew DP, et al. Bare metal stent restenosis is not a benign clinical entity. Am Heart J. 2006;151:1260–1264. doi:10.1016/j.ahj.2005.08.011
   PubMed Web of Science ®Google Scholar
• Yui Y, Hirayama A, Nonogi H, et al. Unstable angina and non-ST elevation acute coronary syndrome: epidemiology and current management in Japan (Japan Multicenter Investigation for Cardiovascular Disease-D (JMIC-D) Committee). Circ J. 2007;71:1335–1347. doi:10.1253/circj.71.1335
   PubMed Web of Science ®Google Scholar
• Inohara T, Kohsaka S, Goto M, et al. Hypothesis of long-term outcome after coronary revascularization in Japanese patients compared to multiethnic groups in the US. PLoS One. 2015;10:e0128252. doi:10.1371/journal.pone.0128252
   PubMed Web of Science ®Google Scholar
• Nakajima K, Takeishi Y, Matsuo S, et al. Metabolic syndrome is not a predictor for cardiovascular events in Japanese patients with diabetes mellitus asymptomatic for coronary artery disease: a retrospective analysis of the J-ACCESS-2 study. J Nucl Cardiol. 2013;20:234–241. doi:10.1007/s12350-012-9656-0
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. John Wiley & Sons; 2011
   Google Scholar
• Kokubo Y, Okamura T, Yoshimasa Y, et al. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the Suita study. Hypertens Res. 2008;31:2027–2035. doi:10.1291/hypres.31.2027
   PubMed Web of Science ®Google Scholar
• Doi Y, Ninomiya T, Hata J, et al. Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study. Stroke. 2009;40:1187–1194. doi:10.1161/STROKEAHA.108.531319
   PubMed Web of Science ®Google Scholar
• Niwa Y, Ishikawa S, Gotoh T, et al. Metabolic syndrome mortality in a population-based cohort study: Jichi Medical School (JMS) cohort study. J Epidemiol. 2007;17:203–209. doi:10.2188/jea.17.203
   PubMed Web of Science ®Google Scholar
• Saito I, Iso H, Kokubo Y, et al. Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) study. Circ J. 2009;73:878–884. doi:10.1253/circj.CJ-08-1025
   PubMed Web of Science ®Google Scholar
• Irie F, Iso H, Noda H, et al. Associations between metabolic syndrome and mortality from cardiovascular disease in Japanese general population, findings on overweight and non-overweight individuals. Ibaraki Prefectural Health Study. Circ J. 2009;73:1635–1642. doi:10.1253/circj.CJ-08-0442
   PubMed Web of Science ®Google Scholar
• Yanai H, Tomono Y, Ito K, et al. The underlying mechanisms for development of hypertension in the metabolic syndrome. Nutr J. 2008;7:10. doi:10.1186/1475-2891-7-10
   PubMed Web of Science ®Google Scholar
• McNeill AM, Rosamond WD, Girman CJ, et al.. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28:385–390. doi:10.2337/diacare.28.2.385
   PubMed Web of Science ®Google Scholar
• Watanabe J, Kakehi E, Kotani K, et al. High-density lipoprotein cholesterol and risk of stroke subtypes: Jichi Medical School Cohort Study. Asia Pac J Public Health. 2020;32:27–34. doi:10.1177/1010539519900685
   PubMed Web of Science ®Google Scholar
• Examination Committee of Criteria for ‘Obesity Disease’ in Japan. Japan Society for the study of obesity. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66:987–992. doi:10.1253/circj.66.987
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–1062. doi:10.1016/S0140-6736(05)67402-8
   PubMed Web of Science ®Google Scholar
• Alehagen U, Vorkapic E, Ljungberg L, et al. Gender difference in adiponectin associated with cardiovascular mortality. BMC Med Genet. 2015;16:37. doi:10.1186/s12881-015-0187-9
   PubMed Web of Science ®Google Scholar
• Glintborg D. Endocrine and metabolic characteristics in polycystic ovary syndrome. Dan Med J. 2016;63:B5232.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol. 2008;79:1544–1551. doi:10.1902/jop.2008.080249
   PubMed Web of Science ®Google Scholar
• Thorand B, Baumert J, Döring A, et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis. 2006;184:216–224. doi:10.1016/j.atherosclerosis.2005.04.011
   PubMed Web of Science ®Google Scholar
• Lai MM, Li CI, Kardia SL, et al. Sex difference in the association of metabolic syndrome with high sensitivity C-reactive protein in a Taiwanese population. BMC Public Health. 2010;10:429. doi:10.1186/1471-2458-10-429
   PubMed Web of Science ®Google Scholar
• Carbone F, Lattanzio MS, Minetti S, et al. Circulating CRP levels are associated with epicardial and visceral fat depots in women with metabolic syndrome criteria. Int J Mol Sci. 2019;20: E5981. doi:10.3390/ijms20235981
   PubMed Web of Science ®Google Scholar
• Hong GB, Gao PC, Chen YY, et al. High-sensitivity C-reactive protein leads to increased incident metabolic syndrome in women but not in men: a five-year follow-up study in a Chinese population. Diabetes Metab Syndr Obes. 2020;13:581–590. doi:10.2147/DMSO.S241774
   PubMed Web of Science ®Google Scholar
• Nishizawa H, Shimomura I. Population approaches targeting metabolic syndrome focusing on Japanese trials. Nutrients. 2019;11: E1430. doi:10.3390/nu11061430
   PubMed Web of Science ®Google Scholar
• Okuda N, Stamler J, Brown IJ, et al. Individual efforts to reduce salt intake in China, Japan, UK, USA: what did people achieve? The INTERMAP population study. J Hypertens. 2014;32:2385–2392. doi:10.1097/HJH.0000000000000341
   PubMed Web of Science ®Google Scholar
• Ogihara T, Asano T, Fujita T. Contribution of salt intake to insulin resistance associated with hypertension. Life Sci. 2003;73:509–523. doi:10.1016/S0024-3205(03)00315-1
   PubMed Web of Science ®Google Scholar